Sumaya Biotech GmbH & Co. KG
PrivateLast Round
Debt
Sep 3, 2021
Company Overview
Sumaya Biotech GmbH & Co. KG operates in Healthcare & Life Sciences and is based in Heidelberg. Its latest recorded funding round was a Debt round in September 2021.
Sumaya Biotech GmbH & Co. KG is a clinical-stage biopharmaceutical company dedicated to the development of malaria vaccines and therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sumaya Biotech GmbH & Co. KG Comparables
Compare Sumaya Biotech GmbH & Co. KG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MalarVx, Inc. | 81% | |
| Sanaria Inc. | 77% | |
| ExpreS2ion Biotech Holding AB | 73% |
For institutional investors. Book with your work email.
Sumaya Biotech GmbH & Co. KG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sumaya Biotech GmbH & Co. KG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EU Malaria Fund | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 158% MoM, reaching 1.1K.
- May 1, 2025
Monthly visitors increased 71% MoM, from 642 to 1.1K.
For institutional investors. Book with your work email.
Sumaya Biotech GmbH & Co. KG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sumaya Biotech GmbH & Co. KG's valuation, stock price, and market status.
Is Sumaya Biotech GmbH & Co. KG a public or private company?
Sumaya Biotech GmbH & Co. KG is a private company.
What is the current stock price of Sumaya Biotech GmbH & Co. KG?
Sumaya Biotech GmbH & Co. KG is a private company, so its shares have no public market price. Caplight tracks Sumaya Biotech GmbH & Co. KG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sumaya Biotech GmbH & Co. KG worth (valuation)?
Valuation information for Sumaya Biotech GmbH & Co. KG is not publicly available.
Can I buy Sumaya Biotech GmbH & Co. KG stock?
Sumaya Biotech GmbH & Co. KG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sumaya Biotech GmbH & Co. KG's last funding round?
Sumaya Biotech GmbH & Co. KG's most recent funding round was Debt on September 3, 2021.
Who are the main investors in Sumaya Biotech GmbH & Co. KG?
Key investors in Sumaya Biotech GmbH & Co. KG include EU Malaria Fund.
Will Sumaya Biotech GmbH & Co. KG IPO soon?
No public IPO plans have been announced for Sumaya Biotech GmbH & Co. KG.
How can I track Sumaya Biotech GmbH & Co. KG secondary market activity?
Caplight tracks bids, offers, and trades in Sumaya Biotech GmbH & Co. KG's shares on secondary markets.